The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo

Publication date: Available online 8 January 2021Source: Antiviral ResearchAuthor(s): Christin Müller, Wiebke Obermann, Nadja Karl, Hans-Guido Wendel, Gaspar Taroncher-Oldenburg, Stephan Pleschka, Roland K. Hartmann, Arnold Grünweller, John Ziebuhr
Source: Antiviral Therapy - Category: Virology Source Type: research